eMed
Miami, Florida, United States · Health Care · 135 employees
eMed® is the world's first end-to-end GLP-1 care platform built on Empathetic AI™. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion.
Funding history
- Series A — $200.0M — Mar 2026
- Venture - Series Unknown — Undisclosed — Aug 2025
Recent signals
- Jul 15, 2026: Tom Brady Partners with eMed to Improve Access to GLP-1 Weight Loss Medications for Employers.
- Mar 26, 2026: Raised $200.0M in Series A
- Aug 18, 2025: Raised funding in Venture - Series Unknown
- Aug 05, 2025: eMed Population Health Appoints Linda Yaccarino as Chief Executive Officer
See plans & pricing → Track eMed ’s funding, hiring, and signals — with verified contacts — on Fundz.